BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 31005210)

  • 1. In-vivo treatment accuracy analysis of active motion-compensated liver SBRT through registration of plan dose to post-therapeutic MRI-morphologic alterations.
    Boda-Heggemann J; Jahnke A; Chan MKH; Ernst F; Ghaderi AL; Attenberger U; Hunold P; Schäfer JP; Wurster S; Rades D; Hildebrandt G; Lohr F; Dunst J; Wenz F; Blanck O
    Radiother Oncol; 2019 May; 134():158-165. PubMed ID: 31005210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term characterization of MRI-morphologic alterations after active motion-compensated liver SBRT: a multi-institutional pooled analysis.
    Dreher C; Sarria GR; Miebach G; Weiss C; Buergy D; Wojtal P; Tavakoli AA; Krug D; Oppitz H; Giordano FA; Both M; Lohr F; Dunst J; Blanck O; Boda-Heggemann J
    Acta Oncol; 2023 Mar; 62(3):281-289. PubMed ID: 37017543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct dose correlation of MRI morphologic alterations of healthy liver tissue after robotic liver SBRT.
    Boda-Heggemann J; Jahnke A; Chan MKH; Ghaderi Ardekani LS; Hunold P; Schäfer JP; Huttenlocher S; Wurster S; Rades D; Hildebrandt G; Lohr F; Dunst J; Wenz F; Blanck O
    Strahlenther Onkol; 2018 May; 194(5):414-424. PubMed ID: 29404626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRI morphologic alterations after liver SBRT : Direct dose correlation with intermodal matching.
    Boda-Heggemann J; Attenberger U; Budjan J; Jahnke A; Jahnke L; Vogel L; Simeonova-Chergou AO; Herskind C; Wenz F; Lohr F
    Strahlenther Onkol; 2016 Sep; 192(9):641-8. PubMed ID: 27393400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intra-breath-hold residual motion of image-guided DIBH liver-SBRT: An estimation by ultrasound-based monitoring correlated with diaphragm position in CBCT.
    Vogel L; Sihono DSK; Weiss C; Lohr F; Stieler F; Wertz H; von Swietochowski S; Simeonova-Chergou A; Wenz F; Blessing M; Boda-Heggemann J
    Radiother Oncol; 2018 Dec; 129(3):441-448. PubMed ID: 30033386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Geometrical tracking accuracy and appropriate PTV margins for robotic radiosurgery of liver lesions by SBRT.
    Liu M; Cygler JE; Vandervoort E
    Acta Oncol; 2019 Jun; 58(6):906-915. PubMed ID: 30799669
    [No Abstract]   [Full Text] [Related]  

  • 7. Online dosimetric evaluation of larynx SBRT: A pilot study to assess the necessity of adaptive replanning.
    Mao W; Rozario T; Lu W; Gu X; Yan Y; Jia X; Sumer B; Schwartz DL
    J Appl Clin Med Phys; 2017 Jan; 18(1):157-163. PubMed ID: 28291932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigating the impact of patient arm position in an MR-linac on liver SBRT treatment plans.
    van den Wollenberg W; de Ruiter P; Nowee ME; Jansen EPM; Sonke JJ; Fast MF
    Med Phys; 2019 Nov; 46(11):5144-5151. PubMed ID: 31529694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosimetric comparison of stereotactic body radiotherapy using 4D CT and multiphase CT images for treatment planning of lung cancer: evaluation of the impact on daily dose coverage.
    Wang L; Hayes S; Paskalev K; Jin L; Buyyounouski MK; Ma CC; Feigenberg S
    Radiother Oncol; 2009 Jun; 91(3):314-24. PubMed ID: 19111362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrasound-based repositioning and real-time monitoring for abdominal SBRT in DIBH.
    Boda-Heggemann J; Sihono DSK; Streb L; Mertens L; Vogel L; Stieler F; Wenz F; Giordano FA; Kalisch I; Lohr F; Fleckenstein J
    Phys Med; 2019 Sep; 65():46-52. PubMed ID: 31430586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical results of mean GTV dose optimized robotic guided SBRT for liver metastases.
    Andratschke N; Parys A; Stadtfeld S; Wurster S; Huttenlocher S; Imhoff D; Yildirim M; Rades D; Rödel CM; Dunst J; Hildebrandt G; Blanck O
    Radiat Oncol; 2016 May; 11():74. PubMed ID: 27236333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosimetric Implications of Residual Tracking Errors During Robotic SBRT of Liver Metastases.
    Chan M; Grehn M; Cremers F; Siebert FA; Wurster S; Huttenlocher S; Dunst J; Hildebrandt G; Schweikard A; Rades D; Ernst F; Blanck O
    Int J Radiat Oncol Biol Phys; 2017 Mar; 97(4):839-848. PubMed ID: 28244421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of dosimetric uncertainty caused by MR geometric distortion in MRI-based liver SBRT treatment planning.
    Han S; Yin FF; Cai J
    J Appl Clin Med Phys; 2019 Feb; 20(2):43-50. PubMed ID: 30697915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of normalized prescription isodose selection for stereotactic body radiation therapy: conventional vs robotic linac.
    Ding C; Solberg TD; Hrycushko B; Xing L; Heinzerling J; Timmerman RD
    Med Phys; 2013 May; 40(5):051705. PubMed ID: 23635253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional image-guided stereotactic body radiation therapy planning for patients with hepatocellular carcinoma.
    Tsegmed U; Kimura T; Nakashima T; Nakamura Y; Higaki T; Imano N; Doi Y; Kenjo M; Ozawa S; Murakami Y; Awai K; Nagata Y
    Med Dosim; 2017 Summer; 42(2):97-103. PubMed ID: 28433483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical impact of removing respiratory motion during liver SABR.
    Gargett M; Haddad C; Kneebone A; Booth JT; Hardcastle N
    Radiat Oncol; 2019 Jun; 14(1):93. PubMed ID: 31159840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereotactic Robotic Body Radiotherapy for Patients With Unresectable Hepatic Oligorecurrence.
    Berkovic P; Gulyban A; Nguyen PV; Dechambre D; Martinive P; Jansen N; Lakosi F; Janvary L; Coucke PA
    Clin Colorectal Cancer; 2017 Dec; 16(4):349-357.e1. PubMed ID: 28462852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental evaluations of the accuracy of 3D and 4D planning in robotic tracking stereotactic body radiotherapy for lung cancers.
    Chan MK; Kwong DL; Ng SC; Tong AS; Tam EK
    Med Phys; 2013 Apr; 40(4):041712. PubMed ID: 23556882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor motion changes in stereotactic body radiotherapy for liver tumors: an evaluation based on four-dimensional cone-beam computed tomography and fiducial markers.
    Shimohigashi Y; Toya R; Saito T; Ikeda O; Maruyama M; Yonemura K; Nakaguchi Y; Kai Y; Yamashita Y; Oya N; Araki F
    Radiat Oncol; 2017 Mar; 12(1):61. PubMed ID: 28335794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.
    Pokhrel D; Sood S; Badkul R; Jiang H; McClinton C; Lominska C; Kumar P; Wang F
    J Appl Clin Med Phys; 2016 May; 17(3):277-293. PubMed ID: 27167284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.